C ongestive heart failure (CHF) is an important cause of atrial fibrillation (AF), with structural remodeling, particularly tissue fibrosis, playing a central role. 1, 2 Fibroblasts are the most abundant cells in the heart. 3 Fibroblast proliferation and differentiation into myofibroblasts are important contributors to arrhythmogenesis under conditions like CHF by enhancing the production of extracellular matrix proteins, such as collagen, and possibly via electric interactions with cardiomyocytes. changes in cardiac fibroblast I K1 in CHF and to define underlying mechanisms and potential functional significance.
Methods

Animal Model
Adult mongrel dogs (22-30 kg) were divided into 2 groups: controls (28 males and 2 females) and dogs with 2-week ventricular tachypacing-induced congestive heart failure (CHF; 21 males and 3 females). Dogs with CHF had unipolar pacing leads inserted fluoroscopically into the right ventricular apex, which were programmed at 240 bpm for 2 weeks. 6 On study days, dogs were anesthetized with morphine (2 mg/kg subcutaneously) and α-chloralose (120 mg/kg intravenously, followed by 29.25 mg/kg per hour) and ventilated mechanically. Effective refractory periods were measured at basic cycle lengths of 150, 200, 250, 300, and 350 ms in the right-atrial appendage, with 10 basic stimuli (S1) followed by a premature extrastimulus (S2) with 5-ms decrements. AF was induced with atrial burst pacing at 50 Hz and 10 V. Mean AF duration was based on 10 AF inductions in each dog. If the mean duration of the first 5 episodes of AF was >2 minutes, AF was induced only 5 times. In 4 dogs per group, tissue sections were analyzed for fibrous-tissue content as previously described, 2 by an investigator blinded to group assignment.
Fibroblast Isolation and Culture
Atrial fibroblasts were obtained from left atria (LA) of adult mongrel dogs as previously described. 7 Hearts were removed after intra-atrial injection of heparin (10 000 U) and immersed in 2 mmol/L of Ca 2+ -containing Tyrode solution. The left coronary artery was cannulated, and the LA tissue was perfused with 2 mmol/L of Ca 2+ Tyrode solution (37°C, 100% O 2 ), then with Ca 2+ -free Tyrode solution (≈10 minutes), followed by ≈60-minute perfusion with the same solution containing collagenase (≈0.48 mg/mL; CLSII, Worthington, OH) and 0.1% bovine serum albumin (Sigma). Cells were dispersed by trituration in KB (Kraftbruhe) solution (when used for electrophysiological study or sample acquisition for mRNA or protein analysis) or Medium 199 (Invitrogen) supplemented with 10% fetal bovine serum (Gibco), penicillin, and streptomycin for culture. Filtration (500-nm nanomesh) was used to remove debris, and cells were then centrifuged at 54.6g for 5 minutes to pellet cardiomyocytes. The supernatant was collected and filtered through 50-μm nanomesh and centrifuged at 314.5g for 10 minutes to concentrate fibroblasts. Freshly isolated fibroblasts were then separated; 1 aliquot was flash-frozen in liquid N 2 and stored for biochemical studies, and the remaining cells were cultured on noncoated glass coverslips. 7 Fibroblasts were incubated in 5% CO 2 /95% O 2 humidified air (37°C). A medium change was performed 4 hours after plating to remove any dead cells and debris, and the medium was changed every 24 hours.
Ionic Current and RMP Recording
All in vitro recordings were obtained at 37°C. The whole-cell perforated-patch technique was used to record RMP in current-clamp mode, and tight-seal patch clamp was used to record I K1 in voltageclamp mode. Borosilicate glass electrodes filled with pipette solution were connected to a patch-clamp amplifier (Axopatch 200A; Axon).
Electrodes had tip resistances of 6 to 8 MΩ. Nystatin-free intracellular solution was placed in the tip of the pipette by capillary action (≈30 s), and then pipettes were backfilled with nystatin-containing (600 μg/mL) pipette solution. 
Ca
2+ Imaging
One-day cultured canine atrial fibroblasts on microscope cover slips were loaded with Fura-2-acetoxymethyl ester (5 μmol/L; Invitrogen) in phenol-free M199 medium in the presence of Pluronic F-127 (20% solution in dimethylsulfoxide, 2.5 μg/mL) for 30 minutes at 36°C in a humidified incubator with 95% air/5% CO 2 . Cover slips were fixed in a perfusion chamber on the stage of a microscope, and fibroblasts were superfused with 1.8 mmol/L of Ca 2+ Tyrode solution and maintained for ≥25 to 30 minutes at room temperature before experimental protocols to allow for deesterification of Fura-2-acetoxymethyl ester. Fura-2 was excited with dual excitation wavelengths at 340 and 380 nm, and emission was recorded at a wavelength of 510 nm. 
Cell Proliferation and Cell Cycle Analysis
Cell cycle was analyzed by flow cytometry as previously described. 8 Atrial fibroblasts were seeded at 4000 cells/cm 2 in T-25 culture flasks (1.0×10 5 cells per flask; 25 cm 2 growth area) and were cultured for 3 days in M199 medium supplemented with 10% fetal bovine serum. The culture medium was replaced with lentivirus-containing medium for each group on day 2. Cells were harvested after 48-hour incubation. After trypsinization, cells were centrifuged at 314.5g for 10 minutes and washed in ice-cold PBS, then fixed overnight in 75% ethanol and stored at −20°C until assayed. For analysis, stored samples were centrifuged at 314.5g for 10 minutes and washed twice in PBS. The pelleted samples were resuspended and incubated in propidium iodide (Sigma) solution for 20 minutes at 4°C. RNase was added in the staining solution to avoid RNA contamination. The stained fibroblast population was gated with forward scatter versus side scatter plot to display the relationship of cell size versus granularity. Data were acquired using a FACScan flow cytometer (BD Biosciences, San Jose, CA), with cell counts obtained during 5 minutes of flow at 60 μL/ min, to create a DNA-content frequency histogram and analyzed with Flowjo software (Tree Star Inc). A Dean-Jett-Fox model was then used to quantify cell-cycle phases, giving the percentages of cells in G0/G1, S, and G2/M. The doublet problem was resolved by a doublet discrimination gate.
KCNJ2 Overexpression and Dominant Negative Constructs
Lentiviral constructs were used, carrying wild-type or dominant negative KCNJ2 cDNAs or pWPI-plasmid negative control expressing green fluorescent protein (GFP) only, as previously reported. 9 Lentivirus preparation was performed as previously described. 10 LA fibroblasts from control dogs were isolated and grown in T75 flasks. At near confluence (3-4 days of culture), fibroblasts were trypsinized, counted, and plated in 12-well plates at 4.4×10 4 cells per well. After 4 to 6 hours of recovery, cells were transduced with lentiviral vectors at 50 multiplicity of infection. After overnight incubation (≈15 hours), cells were washed 3× with 10% fetal bovine serum-containing medium. After an additional 48 hours of culture, electrophysiological studies, Ca 2+ imaging, or flow cytometry was performed. 
Nonstandard Abbreviations and Acronyms
Taqman Real-Time Quantitative Reverse Transcription Polymerase Chain Reaction
Freshly isolated dog fibroblasts were resuspended in a lysis buffer, and RNA was isolated with Nucleospin RNA II (Macherey Nagel), including DNase treatment to prevent genomic contamination. Messenger RNAs were reverse-transcribed with the High-Capacity Reverse Transcription Kit (Applied Biosystems). Quantitative polymerase chain reaction was performed with TaqMan probes and primers from Applied Biosystems for housekeeping genes HPRT, β2-microglobulin, and G6PD, as well as for KCNJ2, collagen-1, collagen-3, fibronectin-1, fibrillin-1, and α-smooth muscle actin (α-SMA). SyBr green primers were used to quantify KCNJ12 and KCNJ4. The geometric mean expression of HPRT, β2-microglobulin, and G6PD was used for normalization. Quantitative polymerase chain reaction reactions were performed with Taqman Gene Expression Master Mix (Applied Biosystems). Reactions were run on a Stratagene MX3000. Relative gene expression values were calculated by the 2 −ΔCt method.
Immunostaining
Freshly isolated and cultured fibroblasts were rinsed with PBS and fixed for 10 minutes with 1:1 acetone:methanol at −20°C, and then cells were blocked for 1 hour with 5% bovine serum albumin at room temperature. The fibroblasts were incubated with mouse anti-α-SMA (1/500; Sigma), goat antivimentin (1/500; Santa Cruz), followed by donkey antimouse IgG-Alexa Fluor 555 (1/500; Invitrogen), donkey anti-rabbit IgG-Alexa Fluor 488 (1/500; Invitrogen), and TOPRO-3 iodide (1/1000; Invitrogen). Fluorescent images were obtained with an Olympus Fluoview FV1000 inverted confocal microscope.
Western Blots
Protein was extracted, quantified, and processed as we previously described. 8 Freshly isolated fibroblasts were lysed in detergent-based buffer (150 mmol/L NaCl, 20 mmol/L Tris-HCl, pH 7.4, 1 mmol/L EDTA, 1 mmol/L EGTA, 1% Nonidet P-40, 1% Triton X-100, 1 mmol/L NaF, 1 mmol/L Na 3 VO 4 , and protease inhibitors). Protein samples were separated by gel electrophoresis and transferred to polyvinylidene difluoride membranes. Membranes were blocked and incubated with mouse anti-α-SMA (1/1000; Sigma), goat antivimentin (1/1000; Santa Cruz), anti-Kir2.1 (1:200; Neuromab), and GAPDH (1/10 000; Fitzgerald) antibodies. Secondary antibodies conjugated to horseradish peroxidase were used for detection via chemiluminescence.
Data Analysis
Clampfit 9.2 (Axon), GraphPad Prism 4.0, and Origin 5.0 were used for data analysis. All data are expressed as mean±SEM. Multiple group statistical comparisons were obtained by 2-way ANOVA, and individual group mean differences were evaluated by Student t tests with Bonferroni correction. A 2-tailed P<0.05 was considered statistically significant. 
Results
Properties of the Model
CHF-Induced Changes in Fibroblast Phenotype
Bright field microscopic images of freshly isolated fibroblasts from each group are shown in Figure 1A , with CHF fibroblasts being systematically larger ( Figure 1B-1D) . Immunoflorescence suggested that CHF fibroblasts exhibited enhanced vimentin and α-SMA expression ( Figure 1E ), an impression confirmed by image quantification ( Figure 1F and 1G). Western blot analysis further supported CHF-induced fibroblast α-SMA and vimentin upregulation ( Figure 1H and 1I). Gene expression mRNA levels corresponding to the extracellular matrix proteins collagen-1, collagen-3, fibronectin-1, and fibrillin-1 were all greater in freshly isolated CHF fibroblasts versus control fibroblasts (Online Figure IIIA and IIIB) . These observations indicate that CHF alters atrial fibroblast phenotype. . Overall data ( Figure 2C ) indicate significantly larger I K1 in CHF. CHF significantly increased the expression of KCNJ2 (Kir2.1) at both mRNA (by 52%) and protein (by 80%) levels ( Figure 2D and 2E). KCNJ12 (Kir2.2) mRNA expression (Online Figure IIIC) was 2 orders of magnitude less than that of KCNJ2 (Online Figure IIID) and was not affected by CHF. KCNJ4 (Kir2.3) was undetectable. CHF significantly increased RMP (from −43.2±0.8 mV, control, to −55.5±0.9 mV; P<0.001; Figure 2F ). Ba 2+ (300 μmol/L) significantly reduced RMP and greatly attenuated the RMP differences between control and CHF fibroblasts, suggesting that they were due to I K1 upregulation in CHF ( Figure 2F ). Similar effects were seen with a 10-fold larger Ba 2+ concentration (3 mmol/L; Figure 2G ). Of note, despite the statistically significant reduction in RMP with Ba 2+ , the fibroblasts maintained a negative RMP, indicating a contribution from conductances other than I K1 .
Changes in I K1 and RMP
To further verify the role of I K1 in fibroblast RMP changes with CHF, we performed the studies shown in Online Figure  IV . Consistent with expected behavior, the current conductance (and particularly the inward current component) was greatly enhanced (Online Figure IVA 
Changes in Fibroblast Ca
2+ Entry Figure 3A and 3B show store-dependent Ca 2+ entry data from control and CHF fibroblasts, respectively. Cells in short-term (20 hours) culture were first exposed to nominally Ca ] i ( Figure 3C ) and storedependent Ca 2+ entry ( Figure 3D ) were greater in CHF cells. We were unable to use Ba 2+ as a probe to inhibit I K1 and study the role of I K1 differences in Ca 2+ entry because Ba 2+ interacts directly with Fura-2.
11 However, increasing [K + ] o to reduce RMP substantially suppressed store-dependent Ca 2+ entry under both control and CHF conditions and greatly reduced the difference between control and CHF values ( Figure 3D ). These results suggest that RMP is a significant determinant of fibroblast Ca 2+ entry and that RMP differences due to I K1 remodeling may contribute to the increased Ca 2+ entry caused by CHF.
Fibroblast Proliferation and Differentiation
To study CHF-induced changes in fibroblast proliferation and differentiation, along with the potential contribution of I K1 remodeling, we had to perform experiments with short-term (3 days) cultured cells. We first verified that 3-day culture does not alter fibroblast I K1 or RMP (Online Figure V) . We then collected fibroblasts for proliferation analysis by flow cytometry. Figure 4A and 4B show representative DNA-content histograms and Dean-Jett-Fox model fitting of control and CHF atrial fibroblasts (G0: resting phase; G1 phase: increased size and ready for DNA synthesis; G2/M phase: cells with doubled DNA content in premitotic and mitotic phases). CHF increased the total cell count and cell content in the G2/M phase ( Figure 4C and 4D ). Mean total cell counts are shown in Figure 4C and percentages in each phase in Figure 4D . CHF significantly increased the percentage of cells in the G2/M phase ( Figure 4D ), indicating increased proliferation. Cultured CHF fibroblasts also showed properties indicating greater myofibroblast differentiation versus control fibroblasts, including altered cell morphology and greater expression of vimentin and α-SMA protein (Online Figure VI) .
I K1 Regulates RMP, Ca 2+ Entry, and Proliferation
The experiments shown in Figure 3 suggest that I K1 may contribute to the control of atrial fibroblast Ca 2+ entry. To explore the functional contributions of I K1 more directly, we used a gene transfer approach to vary the current in fibroblasts. A dominant negative KCNJ2 construct (KCNJ2-DN) with the GYG motif replaced by a triple-alanine (AAA) sequence was used to suppress endogenous KCNJ2 current. Wild-type KCNJ2 overexpression (KCNJ2-OE) was used to enhance the current. KCNJ2-DN and wild-type KCNJ2 were packed into a lentivirus vector containing GFP. A control virus was also prepared that contained only GFP inserted into the lentiviral vector. Infected cells were identified by green fluorescence. Figure 5A shows original recordings of I K1 in fibroblasts infected with controls (lentivirus carrying GFP alone), KCNJ2-DN, and KCNJ2-OE constructs, before and after the addition of 300 μmol/L of Ba 2+ to the superfusate. Currents were reduced by KCNJ2-DN and increased by KCN2-OE and strongly suppressed by Ba
2+
. Figure 5B shows current-voltage relationships, with an inset showing control and KCNJ2-DN currents on an expanded current scale for clearer resolution. KCNJ2-OE greatly increased I K1 , whereas KCNJ2-DN strongly reduced I K1 density. Compatible with a role of I K1 in fibroblast differentiation, cell capacitance increased with KCNJ2-OE ( Figure 5C ). KCNJ2-OE substantially hyperpolarized the RMP, and consistent with the effects of Ba 2+ shown in Figure 2F and 2G, KCNJ2-DN significantly reduced RMP. Exposure to Ba 2+ eliminated the RMP differences among constructs ( Figure 5D and 5E) with full effects seen at 300 μmol/L, consistent with the notion that the RMP differences are caused by changes in I K1 .
We then went on to use the gene transfer approach to confirm directly the ability of I K1 to regulate atrial fibroblast Ca 2+ entry and proliferation. KCNJ2-DN decreased, and KCNJ2-OE increased, the resting Ca 2+ level ( Figure 6A ) and storeoperated Ca 2+ entry ( Figure 6B ). 
MicroRNA-26 Regulation of Atrial Fibroblast I K1
The larger increase in the KCNJ2 protein than mRNA in CHF points to mediation by microRNA. We have previously shown that miR-26 targets I K1 and that its downregulation in cardiomyocytes from animals with sustained AF governs cardiomyocyte I K1 enhancement. 12 We therefore considered the possibility that miR-26 regulation may contribute to the atrial fibroblast I K1 enhancement that we observed in CHF. Expression of the miR-26a isoform was decreased in freshly isolated LA fibroblasts from dogs with CHF, whereas miR-26b Figure 8A ). AMO-26a transfection into atrial fibroblasts with lipofectamine effectively suppressed miR-26a ( Figure 8B , left). To exclude nonspecific effects, we examined miR-21 expression, which was unaffected by AMO-26a ( Figure 8B, right) . We then looked at the result of knocking down miR-26a, to mimic its downregulation in CHF, on I K1 in atrial fibroblasts. Figure 8C shows original recordings from a fibroblast exposed to lipofectamine alone, a fibroblast exposed to a scrambled-control oligonucleotide (AMO-NC), and a fibroblast transfected with AMO-26a. I K1 was clearly larger after AMO-26a exposure, as indicated by the mean currentvoltage data in Figure 8D . Finally, we examined the effect of miR-26a knockdown on atrial fibroblast RMP and noted substantial hyperpolarization ( Figure 8E ).
Discussion
In this study, we analyzed the consequences of CHF-induced I K1 upregulation in fibroblasts on fibroblast function, noting hyperpolarized RMP, enhanced Ca 2+ entry, and increased proliferation indices. The mechanistic role of I K1 changes was supported by genetically modifying I K1 through KCNJ2-OE and knockdown, and the potential contribution of hyperpolarization to CHF-induced fibroblast Ca 2+ entry increases was demonstrated by simultaneous voltage clamp and Ca 2+ microfluorometry. CHF-induced miR-26a downregulation was implicated as the mechanism of KCNJ2/ I K1 upregulation.
Functional Role of Ion Channels in Cardiac Fibroblasts
Although the presence of ion channels in cardiac fibroblasts is well established, 3 their functional role is less clear. Ca 2+ entry via nonselective cation channels of the transient receptor potential family plays a role in fibroblast proliferation, differentiation, and extracellular matrix protein secretion. 8, 13 There is evidence that this action is mediated via Ca 2+ -dependent activation of extracellular signal-related protein kinases 14 and contributes to the AF-related arrhythmogenic substrate. 8, 13 The function of fibroblast K + channels is less clear. Previous work has indicated that Kir channels contribute to RMP determination. In cell coculture systems, myofibroblasts can be shown to couple to cardiomyocytes and alter their electrophysiological properties, inducing a variety of arrhythmogenic mechanisms. 14, 15 Although the importance of fibroblast-cardiomyocyte coupling in vivo is still controversial, mathematical modeling work suggests that it may account for complex fractionated electrogram properties in fibrotic tissues. 16 We have recently evaluated the effects of fibroblast ion channel remodeling on the potential electric and arrhythmogenic interactions between coupled fibroblasts and cardiomyocytes, finding that if fibroblasts were well coupled to cardiomyocytes, fibroblast Kv current downregulation would suppress the AFsubstrate, whereas Kir current upregulation would enhance it. 17 We have also obtained evidence for a profibrotic role of Kv current downregulation, although the underlying mechanism is unclear. 18 Nitric oxide synthesis and proliferation of umbilical cord endothelial cells induced by basic fibroblast growth factor seem to depend on inward-rectifier K + current augmentation. 19 Finally, hyperpolarization increases cytoplasmic [Ca 2+ ] in arteriolar endothelial cells.
20
Novel Elements and Potential Significance
Cardiac fibrosis is an important contributor to cardiac dysfunction and arrhythmogenesis, and it is a particularly significant contributor to the substrate that allows enhanced AF maintenance in CHF. 21 Fibroblasts play a central role in the fibrotic process. 22 Here, we addressed a novel regulatory aspect of fibroblast physiology, functional control by I K1 , along with the remodeling of I K1 and its contribution to altered fibroblast function in a clinically relevant fibrotic paradigm: the CHF-induced atrial profibrillatory substrate. 1, 2 We report for the first time that CHF-related atrial I K1 upregulation and consequent fibroblast hyperpolarization enhance fibroblast Ca 2+ entry and cell proliferation. This work identifies a novel participant in the profibrotic response, with potential implications for the development of novel therapeutic interventions. Ion channels are targets for new antiarrhythmic agents. 23 Our study shows that in addition to altering cardiac electrophysiology, interventions that target I K1 may affect cardiac structural remodeling, particularly because the principal I K1 subunit, KCNJ2/Kir2.1, is common to both cardiomyocytes and fibroblasts. The predominance of KCNJ2 in cardiac I K1 is well recognized. 24 This study indicates that KCNJ2 is similarly predominant in fibroblasts: DN-KCNJ2 almost completely eliminated fibroblast I K1 ( Figure 5B, inset) . I K1 blockers are being developed as potential antiarrhythmic molecules, 25, 26 based on their ability to inhibit cardiomyocyte I K1 and destabilize AF-maintaining rotors. 26, 27 An additional potentially interesting consequence, based on the work reported here, might be the suppression of atrial fibrosis. The converse may also hold. Fibroblasts engineered to overexpress Kir2.1, Nav1.5, and connexin-43 subunits rescue normal propagation and decrease arrhythmia complexity in cocultured cardiomyocyte-fibroblast monolayers. 28 A risk of applying this approach therapeutically might be the profibrotic consequences of increased I K1 .
MicroRNAs are significant control molecules in cardiac remodeling. 29 We have previously shown that miR-26 downregulation contributes to AF-promoting remodeling by upregulating cardiomyocyte I K1 . 12 Here, we have identified an additional potential profibrillatory consequence of diseaserelated miR-26 downregulation: fibroblast activation via fibroblast I K1 upregulation consequent to removal of miR-26 induced negative regulation of the KCNJ2 gene. 
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Potential Limitations
Fibroblast hyperpolarization significantly increased storeoperated Ca 2+ entry by ≈30% ( Figure 7B) ; however, CHF fibroblasts showed an ≈70% increase in Ca 2+ entry ( Figure 3D ). Thus, the hyperpolarization caused by I K1 upregulation is likely not the only factor increasing Ca 2+ entry in CHF fibroblasts. In addition to KCNJ2, miR-26 controls the expression of the gene encoding TRPC3 subunits.
8 TRPC3 subunit upregulation caused by miR-26 downregulation in AF enhances fibroblast Ca 2+ entry. 8 Thus, TRPC3 expression changes caused by CHF-induced miR-26a downregulation likely also contributed to the increased fibroblast Ca 2+ entry observed in CHF fibroblasts in this study.
We performed experiments in isolated fibroblasts to evaluate their cell biology in detail. Analysis of fibroblast properties in situ is greatly complicated by their small size and a dearth of specific probes. Paracrine effects in vivo could significantly alter fibroblast behavior and were not analyzed here. In addition, in this study we measured the fibrous-tissue content only in the LA appendage (Online Figure II) . The distribution of fibrosis may not be uniform in atria.
Fibroblast proliferation might be affected by lentiviral infection. We therefore verified cell counts on culture in control fibroblasts versus lentivirus-GFP infected fibroblasts and found no significant differences (Online Figure VII) .
We used Ba 2+ as one of several tools to compare the contribution of I K1 in CHF fibroblasts with that in control. Ba 2+ can affect a variety of K + currents, and the possibility of nonspecific effects requires caution in the interpretation of data. Evidence against any significant nonspecific effects of Ba 2+ in our system is provided by the results of KCNJ2 knockdown on the response to Ba 2+ (Online Figure VIII) . Ba 2+ had no significant effect on currents once KCNJ2/ I K1 was knocked down, indicating the absence of any significant effect on other currents under our recording conditions.
What New Information Does This Article Contribute?
• CHF leads to the upregulation of the background inward-rectifier potassium current (I K1 ) in atrial fibroblasts, likely by downregulating a microRNA (miR-26) that targets I K1 .
• An increase in atrial fibroblast I K1 hyperpolarizes the cell membrane, enhancing Ca 2+ entry by increasing the driving force for transmembrane Ca 2+ movement.
• These findings define a new pathway for CHF-induced atrial fibrosis involving an increase in I K1 , leading to hyperpolarization and enhanced Ca 2+ entry and resulting in fibroblast activation.
CHF is an important clinical risk factor for atrial fibrillation, the commonest sustained arrhythmia and a major source of morbidity and mortality. Although CHF-induced atrial fibrosis is thought to contribute to the atrial fibrillation substrate, the mechanisms leading to this fibrosis are poorly understood. Moreover, the functional roles of ion channels in fibroblasts, the cells that produce fibrosis, are not well understood. Here, we studied changes in the background inward-rectifier potassium current (I K1 ) in atrial fibroblasts from dogs with CHF induced by ventricular tachypacing. We found significant upregulation of I K1 , which hyperpolarized the resting membrane potential of the fibroblasts. This hyperpolarization enhanced Ca 2+ entry, known to be an important fibroblast-activating mechanism, causing fibroblasts to proliferate. We also found that I K1 upregulation is caused by CHF-induced decreases in atrial fibroblast expression of a microRNA, miR-26, that targets the gene (KCNJ2) encoding I K1 . These findings reveal a new function of fibroblast potassium channels, ie, the control of fibroblast activation, and show that these channels can mediate a pathological arrhythmia-promoting response. Further elucidation of this signaling pathway would provide novel insights into the mechanisms controlling atrial fibrillation and might allow for the development of new therapeutic approaches.
